Home
Solution
Impact
Science
- Publications
About
- Team and Board
News and Events
Contact

Month: January 2026

Xinnate announces that recruitment has started and the first patient has been included in the STEP study with TCP-25

Xinnate announces first patient visit has been completed

by Anna-Karin Lindqvist

Xinnate meddelar att rekryteringen har startat och första patienten har blivit inkluderad i STEP-studien med TCP-25

Xinnate meddelar att första patientbesöket har genomförts10

by Anna-Karin Lindqvist

Recent Posts

Xinnate granted patent in Japan for TCP-25 formulation. The patent further strengthens the global intellectual property protection of the TCP-25 gel.
Xinnate AB har fått patent godkänt i Japan avseende formulering av TCP-25. Patentet är innebär ett ytterligare stärkt globalt immateriellt skydd för TCP-25 gelen.
Xinnate announces that recruitment has started and the first patient has been included in the STEP study with TCP-25
Xinnate meddelar att rekryteringen har startat och första patienten har blivit inkluderad i STEP-studien med TCP-25
First Scientific Publication Reporting Clinical Trial Results for Xinnate’s Proprietary Drug Candidate TCP-25

Archives

February 2026
January 2026
December 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025
January 2025
December 2024
September 2024
May 2024
March 2024
February 2024
March 2023
October 2022
September 2022
July 2022
March 2022
August 2021
October 2020
January 2020

© 2026 Xinnate. All rights reserved